Article

Hemostatic Profiling of Generic Factor Xa Inhibitors Using ROTEM® Viscoelastometry and Multimodal Coagulation Assays: A Real-World Study in a Tunisian Cohort

2026-07-17

Abstract excerpt

<h4>Background: </h4> The emergence of generic direct factor Xa inhibitors like apixaban and rivaroxaban has significantly increased the global availability of essential anticoagulants in developing nations. However, we still lack a detailed understanding of how these generic versions behave in real-world clinical practice. This research offers an initial multimodal evaluation, within a Tunisian population, integr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f739fd0f-692a-50f4-99af-3a3229680f98
DOI: 10.12688/f1000research.184280.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Hemostatic Profiling of Generic Factor Xa Inhibitors Using ROTEM® Viscoelastometry and Multimodal Coagulation Assays: A Real-World Study in a Tunisian CohortDOI 10.12688/f1000research.184280.1Read

The Role of Rotational Thromboelastometry (ROTEM) in Understanding the Coagulation Problems in COVID-19 Associated Critical IllnessSemantic proximity Read

Admission viscoelastic hemostatic assay parameters predict poor long-term intracerebral hemorrhage outcomesSemantic proximity Read

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism (deep vein thrombosis and pulmonary embolism) in four European countriesSemantic proximity Read

The influence of direct oral anticoagulants on thrombin generation on Ceveron TGASemantic proximity Read

Prophylactic Therapy with Emicizumab in Patients with Hemophilia A: Benefits and ChallengesSemantic proximity Read

Real-world experience: Effect of Apixaban on INR, More confusion to providers with inadvertent labSemantic proximity Read

In vitro evaluation of global coagulation potential in the copresence of emicizumab and warfarin in whole blood using rotational thromboelastometrySemantic proximity Read

Antithrombotic and Prohemorrhagic Actions of Different Concentrations of Apixaban in Patients Exposed to Single and Dual Antiplatelet RegimensSemantic proximity Read

Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism.Semantic proximity Read

Field Study and Correlative Studies of Factor IX Variant FIX-R338L in Participants Treated with Fidanacogene ElaparvovecSemantic proximity Read

Evaluation of recombinant factor VIII Fc (Eloctate) activity by thromboelastometry in a multicenter phase 3 clinical trial and correlation with bleeding phenotype.Semantic proximity Read

Anticoagulation Therapy for Venous Thromboembolism From Vitamin K Antagonists to Direct Oral Anticoagulants and BeyondSemantic proximity Read